Literature DB >> 19873943

Outcome study of unilateral lateral rectus recession for small to moderate angle intermittent exotropia in children.

Lihua Wang1, Leonard B Nelson.   

Abstract

PURPOSE: To report an outcome study of 100 consecutive children with intermittent exotropia treated by unilateral rectus recession for small to moderate angle exodeviation with a minimum follow-up of 6 months.
METHODS: The records of patients with intermittent exotropia younger than 15 years who underwent 7-to-10-mm unilateral lateral rectus recession for exodeviation measuring 15 to 35 prism diopters (PD) from January 2000 to July 2008 were retrospectively reviewed. The surgery were performed accordingly to the amount of distance deviation. A successful alignment was defined as an exodeviation of 5 PD or less and absence of any esotropia in primary and lateral gaze while viewing distant or near targets.
RESULTS: Successful alignment was achieved in 99%, 88%, and 76% of patients at early postoperative, 6-month, and final follow-up, respectively. One overcorrected patient had an esodeviation of 20 PD at 6 months. The results of the final follow-up did not depend on age or refraction at the level of 0.05, whereas the amount of initial exodeviation was found to be significantly correlated with success at the final examination (P = .041). There was a positive significant relationship between results at 6 months and final follow-up (P = .000, r = 0.449). Eleven of the 13 patients who had a second surgery and were observed more than 6 months had successful alignment. Eighty-nine percent of the patients achieved a successful outcome with the combined primary and secondary surgery at the final follow-up.
CONCLUSION: Unilateral lateral rectus recession is a safe and effective treatment for small to moderate angle intermittent exotropia in children.

Entities:  

Mesh:

Year:  2010        PMID: 19873943     DOI: 10.3928/01913913-20091019-12

Source DB:  PubMed          Journal:  J Pediatr Ophthalmol Strabismus        ISSN: 0191-3913            Impact factor:   1.402


  9 in total

1.  Comparison of Postoperative Exodrift after First Unilateral and Second Contralateral Lateral Rectus Recession in Recurrent Exotropia.

Authors:  Eun Yeong Kim; Hyun Kyung Kim; Se Youp Lee; Young Chun Lee
Journal:  Korean J Ophthalmol       Date:  2016-01-21

2.  Prognostic preoperative factors for successful outcome of surgery in horizontal strabismus.

Authors:  Namita Kumari; Abadan Khan Amitava; Mohammad Ashraf; Shivani Grover; Ashiya Khan; Prabha Sonwani
Journal:  Oman J Ophthalmol       Date:  2017 May-Aug

3.  Prevalence and risk factors of strabismus in children and adolescents in South Korea: Korea National Health and Nutrition Examination Survey, 2008-2011.

Authors:  Kyung Eun Han; Seung-Hee Baek; Seung-Hyun Kim; Key Hwan Lim
Journal:  PLoS One       Date:  2018-02-14       Impact factor: 3.240

4.  Stepped Strabismus Surgery.

Authors:  Amr Elkamshoushy; Ahmed Kassem
Journal:  Clin Ophthalmol       Date:  2021-04-28

5.  A Prospective Study of One-Muscle Surgery in 15-25 Prism Diopters Horizontal Comitant Strabismus in Adults.

Authors:  Apatsa Lekskul; Wadakarn Wuthisiri; Nicha Jarupanich
Journal:  Clin Ophthalmol       Date:  2021-08-31

6.  Predictive Factors Affecting Long-Term Outcome of Unilateral Lateral Rectus Recession.

Authors:  Hee Kyung Yang; Mi-Jin Kim; Jeong-Min Hwang
Journal:  PLoS One       Date:  2015-09-29       Impact factor: 3.240

7.  Long-term outcomes of unilateral lateral rectus recession versus recess-resect for intermittent exotropia of 20-25 prism diopters.

Authors:  Hae Jin Kim; Dongwook Kim; Dong Gyu Choi
Journal:  BMC Ophthalmol       Date:  2014-04-08       Impact factor: 2.209

8.  The use of one muscle recession for horizontal strabismus.

Authors:  Fyqah H Almahmoudi; Mohammed Al Shamrani; Abdullah M Khan
Journal:  Saudi J Ophthalmol       Date:  2018-05-18

9.  Comparison of surgery versus observation for small angle intermittent exotropia.

Authors:  Jae Yun Sung; Hee Kyung Yang; Jeong-Min Hwang
Journal:  Sci Rep       Date:  2020-03-13       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.